Anyone paying attention should have seen this coming. But that kind of reaction to announcing a test for advertising seems a bit overblown, even if the market encompasses more than 500 million ...

Biogen and Japanese drugmaker Eisai created a surge in hope for an experimental Alzheimer’s drug called BAN2401, after the companies announced positive results in a late-stage trial. That hope ...

After over a year of touting its logged-out audience, Twitter is starting to test monetization of visitors to its website that aren't logged into an account. The market cheered the announcement, ...